Evidence map›Paper›PMID 40741051›Full record

ArticleRSC medicinal chemistry2025

Design of chitosan-coated CeO

Hina Afzal, Muhammad Babar Taj, Merfat M Alsabban, Walla Alelwani, Nadiyah Alahmadi, Noushi Zaidi, Nouf A Babteen, Sana Afzal

Abstract read
In one paragraph

Article in RSC medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hina AfzalInstitute of Chemistry, Islamia University of Bahawalpur Bahawalpur Pakistan dr.taj@iub.edu.pk.
Muhammad Babar TajInstitute of Chemistry, Islamia University of Bahawalpur Bahawalpur Pakistan dr.taj@iub.edu.pk.ORCID https://orcid.org/0000-0001-5343-6893
Merfat M AlsabbanDepartment of Chemistry, College of Science, University of Jeddah Jeddah 21959 Saudi Arabia.
Walla AlelwaniDepartment of Biological Sciences, College of Science, University of Jeddah Jeddah Saudi Arabia.
Nadiyah AlahmadiDepartment of Chemistry, College of Science, University of Jeddah Jeddah 21959 Saudi Arabia.
Noushi ZaidiDepartment of Basic Sciences, Preparatory Year, King Faisal University Al-Ahsa 31982 Saudi Arabia.
Nouf A BabteenDepartment of Biological Sciences, College of Science, University of Jeddah Jeddah Saudi Arabia.
Sana AfzalInstitute of Chemistry, Islamia University of Bahawalpur Bahawalpur Pakistan dr.taj@iub.edu.pk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional ways of formulating azithromycin are characterized by low oral bioavailability. Therefore, the development of new formulations to enhance drug bioavailability is crucial. The current study aims to evaluate the

Identifiers

PMID40741051
PMCPMC12305675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.